Form 8-K - Current report:
SEC Accession No. 0001193125-24-229480
Filing Date
2024-10-01
Accepted
2024-10-01 06:36:29
Documents
14
Period of Report
2024-09-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d845252d8k.htm   iXBRL 8-K 28764
2 EX-99.1 d845252dex991.htm EX-99.1 27269
  Complete submission text file 0001193125-24-229480.txt   191168

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sttk-20240930.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sttk-20240930_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sttk-20240930_pre.xml EX-101.PRE 11717
16 EXTRACTED XBRL INSTANCE DOCUMENT d845252d8k_htm.xml XML 3762
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 241341256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)